AstraZeneca AZD1222 Subscribe help_outline Mar 22, 2021AstraZeneca's reported the results of its US Phase III clinical trial. They reported a 79% vaccine efficacy at preventing symptomatic COVID-19, and 100% efficacy against severe or critical disease and hospitalisation.
Mar 22, 2021AstraZeneca's reported the results of its US Phase III clinical trial. They reported a 79% vaccine efficacy at preventing symptomatic COVID-19, and 100% efficacy against severe or critical disease and hospitalisation.
